D-1445-2014 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-1445-2014 was initiated by Sandoz Inc on Jul 11, 2014 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing. The recall status is terminated (terminated Jul 10, 2017). Affected quantity: 781,000 extended release tablets.

Recall details

Product Type
Drugs
Report Date
Jul 30, 2014
Initiation Date
Jul 11, 2014
Termination Date
Jul 10, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
781,000 extended release tablets

Product description

Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.

Reason for recall

Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.

Distribution pattern

Nationwide

Code information

Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1445-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1445-2014. Report a data issue: hello@regdatalab.com.